Newsroom

LONDON--(BUSINESS WIRE)--  Xtrackers (IE) plc Investment Company with Variable Capital Registered Office: 78 Sir John Rogerson's Quay, Dublin 2, Ireland Registration number: 393802 (the “Company”) NOTICE TO SHAREHOLDERS OF THE SUB-FUNDS LISTED ON THE LONDON STOCK EXCHANGE Dublin, 12 November 2026 This announcement is to inform the shareholders of the sub-funds listed in the table below (each a Sub-Fund, and together the Sub-Funds) (the Shareholders) on behalf of the board of directors of the Co...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Eurozone AlphaDEX UCITS ETF 12.11.2026 FEUZ IE00B8X9NY41 1,581,130.00 EUR 103,895,486.12   65.710  ...

BOSTON--(BUSINESS WIRE)--Liberty All-Star® Growth Fund, Inc. October 2026 Monthly Update...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Emerging Markets AlphaDEX UCITS ETF 12.11.2026 FEM IE00B8X9NX34  300,002.00 USD  14,461,975.73   48.206  ...

NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of NVIDIA Corporation (NASDAQ: NVDA) between December 19, 2024 and November 12, 2026, both dates inclusive (the “Class Period”). The Class Period was expanded to include more investors. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 8, 2027 in th...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Large Cap Core AlphaDEX UCITS ETF 12.11.2026 FEXD.LN IE00BWTNMB87  440,903.00 USD  44,583,264.36  101.118  ...

BOSTON--(BUSINESS WIRE)--Liberty All-Star® Equity Fund October 2026 Monthly Update...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Large Cap Core AlphaDEX UCITS ETF 12.11.2026 FEX.LN IE00B8X9NW27 1,372,712.00 USD 157,036,442.35  114.399  ...

KOŠICE, Slovakia--(BUSINESS WIRE)--VELOCIFERO takes legal action against alleged counterfeiting in China, resulting in suspected counterfeit vehicle seizures in Chongqing and Taizhou....

BAAR, Switzerland--(BUSINESS WIRE)--Novocure (Nasdaq: NVCR) announced today that JAMA Network Open published the results of the prespecified secondary analysis of data from the Phase 3 PANOVA-3 trial of Tumor Treating Fields (TTFields) therapy concomitant with gemcitabine and nab-paclitaxel in patients with unresectable, locally advanced pancreatic adenocarcinoma. The PANOVA-3 trial evaluated the use of TTFields therapy concomitantly with gemcitabine and nab-paclitaxel (GnP) as a first-line tre...